Abstract:Background: Pathological cardiac fibrosis and hypertrophy, the common features of left ventricular remodeling, often progress to heart failure. Forkhead box transcription factor P1 (Foxp1) in endothelial cells (ECs) has been shown to play an important role in heart development. However, the effect of EC-Foxp1 on pathological cardiac remodeling has not been well clarified. This study aims to determine the role of EC-Foxp1 in pathological cardiac remodeling and the underlying mechanisms. Methods: Foxp1 EC-specific loss-of-function and gain-of-function mice were generated, and an angiotensin II infusion or a transverse aortic constriction operation mouse model was used to study the cardiac remodeling mechanisms. Foxp1 downstream target gene transforming growth factor-beta 1 (TGF-beta 1) was confirmed by chromatin immunoprecipitation and luciferase assays. Finally, the effects of TGF-beta 1 blockade on EC-Foxp1 deletion-mediated profibrotic and prohypertrophic phenotypic changes were further confirmed by pharmacological inhibition, more specifically by RGD-peptide magnetic nanoparticle target delivery of TGF-beta 1-siRNA to ECs. Results: Foxp1 expression is significantly downregulated in cardiac ECs during angiotensin II-induced cardiac remodeling. EC-Foxp1 deletion results in severe cardiac remodeling, including more cardiac fibrosis with myofibroblast formation and extracellular matrix protein production, as well as decompensated cardiac hypertrophy and further exacerbation of cardiac dysfunction on angiotensin II infusion or transverse aortic constriction operation. In contrast, EC-Foxp1 gain of function protects against pathological cardiac remodeling and improves cardiac dysfunction. TGF-beta 1 signals are identified as Foxp1 direct target genes, and EC-Foxp1 deletion upregulates TGF-beta 1 signals to promote myofibroblast formation through fibroblast proliferation and transformation, resulting in severe cardiac fibrosis. Moreover, EC-Foxp1 deletion enhances TGF-beta 1-promoted endothelin-1 expression, which significantly increases cardiomyocyte size and reactivates cardiac fetal genes, leading to pathological cardiac hypertrophy. Correspondingly, these EC-Foxp1 deletion-mediated profibrotic and prohypertrophic phenotypic changes and cardiac dysfunction are normalized by the blockade of TGF-beta 1 signals through pharmacological inhibition and RGD-peptide magnetic nanoparticle target delivery of TGF-beta 1-siRNA to ECs. Conclusions: EC-Foxp1 regulates the TGF-beta 1-endothelin-1 pathway to control pathological cardiac fibrosis and hypertrophy, resulting in cardiac dysfunction. Therefore, targeting the EC-Foxp1-TGF-beta 1-endothelin-1 pathway might provide a future novel therapy for heart failure.

Abstract We032: FOXK1-Gli2 Network Regulates Cardiomyocyte Proliferation and Heart Regeneration

FOXK1 Regulates Wnt Signalling to Promote Cardiogenesis.

The Neural Progenitor Cell-Associated Transcription Factor FoxG1 Regulates Cardiac Epicardial Cell Proliferation

Abstract 17134: Mycn is a Regulator of Cardiomyocyte Proliferation and Regeneration in the Mammalian Heart

Foxk1 Promotes Cell Proliferation and Represses Myogenic Differentiation by Regulating Foxo4 and Mef2.

Abstract P2029: The Role Of Runx1 In Cardiomyocyte Cell Cycle Activity And Its Impact On Cardiac Regeneration

Foxp1 Coordinates Cardiomyocyte Proliferation Through Both Cell-Autonomous and Nonautonomous Mechanisms

Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1–Endothelin-1 Signal Pathway

Abstract 14474: Cdk9-activated Sgk3 Promotes Myocardial Repair and Regeneration after Myocardial Infarction Via Gsk-3Å/Å-catenin Pathway

Foxm1 regulates cardiomyocyte proliferation in adult zebrafish after cardiac injury.

Foxm1 drives cardiomyocyte proliferation in adult zebrafish after cardiac injury

LRP5 Regulates Cardiomyocyte Proliferation and Neonatal Heart Regeneration by the AKT/P21 Pathway.

Integrated transcriptomic and proteomic analysis reveals potential targets for heart regeneration

Abstract 12312: Mnk2 Kinase Promotes Cardiomyocyte Proliferation Via Eif4e Phosphorylation in Mouse Heart after Myocardial Infarction

Abstract P1026: Creg1 Inhibits Cardiomyocyte Proliferation And Promotes Myocardial Differentiation And Compaction During Postnatal Cardiac Development

MNK2-eIF4E axis promotes cardiac repair in the infarcted mouse heart by activating cyclin D1

Murine neonatal cardiac regeneration depends on Insulin-like growth factor 1 receptor signaling

Abstract 18695: C5ORF51/RIMOC1 - A Novel Regulator of Cardiogenesis

Foxk1 Recruits the Sds3 Complex and Represses Gene Expression in Myogenic Progenitors

gp130 Controls Cardiomyocyte Proliferation and Heart Regeneration

Abstract 14700: Notch1 Overexpression Reprograms Adult Myocytes to an Immature Functional Phenotype